Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are 8 years of age or older.
- People who have a single brain tumor (either a new tumor or one that has come back) and have also experienced seizures linked to that tumor. The tumor can be identified by a scan rather than surgery. The seizures need to have started within three months of the tumor being spotted on a scan, or — if the timing is unclear — the type of seizure fits with where the tumor is located. Having had just one seizure in the past is enough to meet this requirement, and people whose seizures stopped after starting anti-seizure medication are still eligible.
Who may not be able to join:
- People who, at the time of joining the trial, are unable to understand an explanation of the study procedures due to a level of cognitive impairment that removes their ability to give informed consent. Note: children may still be eligible if a parent or guardian is able to give consent on their behalf, and adults with mental health conditions or mild cognitive difficulties who are still able to consent are not excluded on this basis. (Confirm with trial site how consent capacity will be assessed.)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Kareem A Zaghloul, M.D., National Institute of Neurological Disorders and Stroke (NINDS)
Phone: (301) 496-2921
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
change in seizure frequency, as measured by the Engel scale
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.